| Name | Title | Contact Details |
|---|
We are at the cutting-edge of medical development – and through our advanced clinical trials, novel medical device development and in-house cellular manufacturing and quality control expertise, we intend to lead the industry. We are uniquely positioned and expect to maintain our leadership position though active collaborations with physicians, researchers, hospitals and blood banks on a wide range of clinical, cell-based approaches to medical treatment.
At Memorial Hermann, we are all about advancing health. Yours. It begins by redefining healthcare. Our 6,400 affiliated physicians and more than 26,000 employees practice evidence-based medicine with a relentless focus on quality, safety and exceptional service for all patients, consumers and Health Plan members. Our efforts continue to result in national awards and recognition, including for our nationally acclaimed Accountable Care Organization. With a focus on providing enhanced access to care, Memorial Hermann offers Virtual Clinic for digital access and has 300 care delivery sites conveniently located across the Greater Houston area, including our flagship hospital in the world-renowned Texas Medical Center, which serves as the teaching hospital for McGovern Medical School at UTHealth. We have proudly served this community for more than 110 years, and we contribute more than $588 million annually through school-based health centers and other community benefit programs. Because at Memorial Hermann, the health of our community is always at the center of what we do. Learn more about Memorial Hermann Health System.
Bioexpressions is a Mill Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aspen Health Svc is a Santa Ana, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin`s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin`s first FDA approved product and is available in the United States by prescription.